DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

145.37 2.69 (1.89%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $145.37 1.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $144.28
Previous Close $142.68
Daily Range $143.06 - $146.58
52-Week Range $105.17 - $153.10
Market Cap $48.8B
P/E Ratio 92.65
Dividend (Yield) $0.00 (0.0%)
Volume 2,258,349
Average Daily Volume 2,844,268
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

George Soros Just Bought These 3 Stocks: Should You?

Controversial billionaire George Soros purchased large stakes in AbbVie, Actavis plc, and Valeant Pharmaceuticals in the third-quarter. Should you follow in his footsteps?

Valeant May Actually Be A Good Investment Right Now

Shire to Relocate Employees Under One Shire Program - Analyst Blog

Synergy Pharmaceuticals Drug Fares Well in Phase II Study - Analyst Blog

Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog

Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog

The Viveve System Offers Better Alternative To Treat Vaginal Laxity

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

Zoetis to Buy Abbott's Animal Health Assets for $255 Million - Analyst Blog

Benzinga's M&A Chatter for Tuesday November 18, 2014

Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $145.37 (1.89%)
Current stock: VRX
PFE $30.45 (0.03%)
Current stock: PFE
JNJ $107.86 (0.35%)
Current stock: JNJ
RHHBY $37.33 (-0.93%)
Current stock: RHHBY